C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2011
10/12/2011	EP2373680A2 Delta-opioid receptor selective analgesics
10/12/2011	EP2373679A2 Mini-hepcidin peptides and methods of using thereof
10/12/2011	EP2373678A1 Anticancer compounds
10/12/2011	EP2035442B1 New supported oxidation reactants, process for their preparation and uses thereof
10/12/2011	EP1541584B1 A group of novel synthetic antibiotic peptides
10/12/2011	EP1263471B1 Antimicrobial compounds and formulations
10/12/2011	CN102216469A High-throughput assay for evaluating dipeptidyl peptidase i activity
10/12/2011	CN102216325A Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
10/12/2011	CN102216322A Inhibiting interaction between the hif-1alpha and p300/cbp with hydrogen bond surrogate-based
10/12/2011	CN102212118A Antibacterial peptide B and application thereof
10/12/2011	CN102212117A Antibacterial peptide A and application thereof
10/12/2011	CN102212116A Acetylcholine receptor mediated brain-targeted polypeptide and application thereof
10/12/2011	CN102212115A Newly found hepatitis C virus epitope
10/12/2011	CN102212114A New hepatitis C virus epitope
10/12/2011	CN102212113A Tuberculosis medicament resistance related tuberculosis-resisting cytotoxic T lymphocyte (CTL) epitope peptide derived from refflux protein and application thereof
10/12/2011	CN102212112A MTA1 (metastasis-associated gene 1)-derived anti-tumor CTL (cytotoxic T lymphocyte) epitope peptide and application thereof
10/12/2011	CN102212111A Micromolecule polypeptide and micromolecule polypeptide liposome as well as applications thereof
10/12/2011	CN102212110A Beta-lactamase inhibitory peptide and application thereof
10/12/2011	CN102212109A Bone polypeptide compound separated from ossotide injection and application thereof
10/12/2011	CN102212108A Determination and application of human RACK1 (receptor for activated C kinase 1) epitope interacting with MKK7 (mitogen-activated protein kinase kinase 7)
10/12/2011	CN101921311B Anti-freeze polypeptide prepared by enzymolysis of cow leather collagen through papain
10/12/2011	CN101585867B Method for separating and purifying microcystin
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034899 HIV fusion inhibitor peptides with improved biological properties
10/11/2011	US8034898 Methods of collagen imaging
10/11/2011	US8034781 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/11/2011	US8034779 Inhibitors of BCL-2
10/11/2011	US8034774 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
10/11/2011	US8034773 Immunostimulatory compositions and uses thereof
10/11/2011	US8034763 Platelet aggregation inhibitor composition
10/11/2011	US8034762 Treatment of subarachnoid hemorrhage with Apo E analogs
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2447538C Cellular signal-responsive gene transcriptional regulation system
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2416475C Medicinal uses of mu-opioid receptor agonists
10/06/2011	WO2011123858A2 Ccn3 peptides and analogs thereof for therapeutic use
10/06/2011	WO2011123826A2 Prevention and treatment of cast nephropathy
10/06/2011	WO2011123652A1 Rfamide-related peptides and methods thereof
10/06/2011	WO2011123061A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same
10/06/2011	WO2011122944A1 Pea protein peptides with anti helicobacter pylori activity
10/06/2011	WO2011122937A1 Pea protein peptides with anti helicobacter pylori activity
10/06/2011	WO2011122611A1 Cancer vaccine
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	WO2011120842A1 Purification of caspofungin intermediates
10/06/2011	WO2011120359A1 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
10/06/2011	WO2011120071A1 Oxytocin peptide analogues
10/06/2011	WO2010089554A8 Grass peptides for vaccine
10/06/2011	US20110245187 Mesenchymal cell proliferation promoter and skeletal system biomaterial
10/06/2011	US20110245176 Novel peptides that bind to the erythropoietin receptor
10/06/2011	US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED
10/06/2011	US20110245167 NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof
10/06/2011	US20110245155 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
10/06/2011	US20110244513 Isolated mammalian membrane protein genes; related reagents
10/06/2011	US20110244498 Tyrosine kinase-inducible domains
10/06/2011	US20110244491 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
10/06/2011	US20110243981 Therapeutic myelin sheath derived antagonist peptide conjugates
10/06/2011	US20110243978 Enterococcus antigens
10/06/2011	US20110243974 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
10/06/2011	US20110243972 Prostate stem cell antigen vaccines and uses thereof
10/06/2011	US20110243960 Methods and compositions for treating p. acnes
10/06/2011	US20110243950 Msp2 antigenic peptides and their use
10/06/2011	US20110243949 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	CA2795400A1 Prevention and treatment of cast nephropathy
10/05/2011	EP2371854A2 Induction of tumor immunity by variants of folate binding protein
10/05/2011	EP2371840A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371375A1 Peptide for inhibiting skin aging
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/05/2011	EP2370454A1 Wdrpuh epitope peptides and vaccines containing the same
10/05/2011	EP2370100A1 Peptide adjuvants
10/05/2011	EP2370088A2 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
10/05/2011	EP1923463B1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hla-a2-positive patient and pharmaceutical comprising the antigen
10/05/2011	EP1711604B1 Diabetogenic epitopes
10/05/2011	EP1492814B1 Interleukin-1-beta derived peptide and its therapeutic application
10/05/2011	CN102206254A Lysine decarboxylase epitope, anti-decarboxylase epitope antibody and application thereof
10/05/2011	CN102206253A Actin depolymerizing factor epitope, actin depolymerizing factor antibody and use thereof
10/05/2011	CN102206252A Presenilin-5 inhibitive factor antigen epitope, anti-presenilin-5 inhibitive factor antibody and purpose thereof
10/05/2011	CN102206251A Acyl carrier protein III epitope, acyl carrier protein III antibody and use thereof
10/05/2011	CN102206250A Low hematolysis antimicrobial peptide, pharmaceutical composition and use thereof
10/05/2011	CN102206249A Specific B cell epitope polypeptide of NS1 protein of encephalitis B virus and use thereof
10/05/2011	CN102206248A Compound for detecting nickel ions
10/05/2011	CN102206247A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/05/2011	CN101585866B Polypeptide for regulating activity of FGFR3 and screening method and application thereof
10/05/2011	CN101402676B Polyglycols modified disinfection/neutralization endotoxin polypeptide, preparation and uses thereof
10/05/2011	CN101278051B Personal care compositions and methods for their use
10/04/2011	US8030464 Stabilized bioactive peptides and methods of identification, synthesis, and use
10/04/2011	US8030447 Substrate peptide sequences for plague plasminogen activator and uses thereof
10/04/2011	US8030446 Mutant proline-and-arginine rich peptides and methods for using the same
10/04/2011	US8030445 Glycopeptide derivative
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	US8030074 In vivo incorporation of unnatural amino acids
10/04/2011	US8029801 HN epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
09/2011
09/29/2011	WO2011119008A2 Peptides for promoting angiogenesis and an use thereof
09/29/2011	WO2011117448A1 Compounds for use in the treatment of diseases based on the expression of toxic transcripts
09/29/2011	WO2011116411A1 Salt-resistant emulsions
09/29/2011	US20110237688 Methods and compositions related to acetylocholine receptor conjugates

1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 423